(Q35765142)

10 August 2017

1 reference

title

Is proteinuria a plausible target of therapy? (English)

1 reference

10 August 2017

Dave C Y Chua

1

1 reference

10 August 2017

George L Bakris

series ordinal

2

1 reference

10 August 2017

publication date

1 June 2004

1 reference

10 August 2017

number of pages

5

1 reference

Current Hypertension Reports

inferred from page(s)

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

177-181

1 reference

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

10 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0066-9

Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0066-9

The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0066-9

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

1 reference

12 December 2020

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

12 December 2020

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

1 reference

12 December 2020

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

1 reference

12 December 2020

Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

1 reference

12 December 2020

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects

1 reference

12 December 2020

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

12 December 2020

End-stage renal disease in African-American and white men. 16-year MRFIT findings

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

12 December 2020

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

12 December 2020

Renal handling of albumin: a critical review of basic concepts and perspective

1 reference

12 December 2020

American Diabetes Association: clinical practice recommendations 2002

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients

1 reference

12 December 2020

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

1 reference

12 December 2020

C-reactive protein modifies the relationship between blood pressure and microalbuminuria

1 reference

12 December 2020

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

1 reference

12 December 2020

Dialysis delayed is death prevented: a clinical perspective on the RENAAL study

1 reference

12 December 2020

Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension

1 reference

12 December 2020

Dosing angiotensin II blockers—beyond blood pressure

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Treatment of hypertension in patients with renal disease

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury

1 reference

12 December 2020

Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes

1 reference

12 December 2020

Renal responses to antagonism of the renin-angiotensin system.

1 reference

12 December 2020

The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with [...]

1 reference

12 December 2020

10.1007/S11906-004-0066-9

Identifiers

DOI

1 reference

release_r7aw72lpgveg7cwwduc7lreu4y

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r7aw72lpgveg7cwwduc7lreu4y

24 November 2022

mapped directly with Wikidata item

1 reference